Has Ryan Connley received payments from drug or device companies?

Yes. Drug and device makers reported $5,581 in general payments to Ryan Connley across 211 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Connley did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Connley come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Connley

Psychiatric/Mental Health · Cincinnati, OHNPI 1356082739

Payments from drug & device makers

$5,581in general payments, 2019–2025

Across 211 payments — averaging $26.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$1K
Otsuka America Pharmaceutical, Inc.$750
AbbVie$717
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$695
Supernus Pharmaceuticals, Inc.$486
Alkermes, Inc.$359
plus $1K from 12 others

What the payments were for

Food & beverage$5,50699%
Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	16	$1,258
Otsuka America Pharmaceutical, Inc.	41	$750
AbbVie	37	$717
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	32	$695
Supernus Pharmaceuticals, Inc.	10	$486
Alkermes, Inc.	19	$359
Lundbeck LLC	12	$263
Corium, LLC	7	$252
Axsome Therapeutics, Inc.	4	$206
Ironshore Pharmaceuticals Inc.	13	$184
Teva Pharmaceuticals USA, Inc.	6	$134
Neurocrine Biosciences, Inc.	3	$76
Indivior Inc.	4	$65
Tris Pharma Inc	3	$49
Vanda Pharmaceuticals Inc.	1	$34
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$25
Vertical Pharmaceuticals, LLC	1	$14
Collegium Pharmaceutical, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,581 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Vilazodone Hcl	12	$1,211
Guanfacine Hcl ErGuanfacine Hcl	24	$938
Trazodone Hcl	44	$374
Buspirone Hcl	12	$128

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Cincinnati

Terri PopovitzCincinnati$161K
Michelle McBrideCincinnati$29K
Seth FramptonCincinnati$10K
Crystal TravisJackson$333K
Kristina RoweIronton$253K
Patricia SparksPortsmouth$210K
Mary HallWarren$195K
Kassandra KornbauCanfield$170K
Steven MatesDayton$121K
Robert ParsonsYoungstown$119K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →